APCS (serum amyloid P component) is an acute-phase protein with multifaceted immunomodulatory functions. Structurally, APCS acts as a calcium-dependent lectin capable of binding carbohydrates and interacting with DNA, histones, and the complement C1q complex [UniProt]. Its primary role involves scavenging nuclear material released from damaged circulating cells and participating in innate immune responses [UniProt]. APCS negatively regulates acute inflammatory responses, monocyte differentiation, and viral processes, while also suppressing host-symbiont invasion [GO annotations]. The protein is present in extracellular exosomes and participates in chaperone-mediated protein complex assembly [GO annotations]. Clinically, APCS is associated with multiple disease states including amyloidosis variants (AL amyloidosis), atrial fibrillation, congestive heart failure, idiopathic pulmonary fibrosis, and various infections including bacterial pneumonia and acute tonsillitis [NCBI disease associations]. Its involvement in atrial fibrillation and cardiac disease likely reflects its immune-regulatory functions during inflammation. The protein's ability to modulate complement activation and inflammatory responses positions it as a key player in both protective immunity and pathological inflammation. However, the provided abstracts do not contain specific mechanistic data on APCS function in disease states.